Parkinson's Disease treatment

Nuplazid for Parkinson’s Disease

Nuplazid (pimavanserin) is an FDA-approved treatment specifically for Parkinson’s-related hallucinations and delusions. It works differently from traditional antipsychotics, offering benefits without worsening motor symptoms. It doesn’t treat the disease itself but helps ease disturbing psychiatric symptoms.

Why Choose Nuplazid?

Unlike many antipsychotics that block dopamine (which Parkinson’s patients already lack), Nuplazid targets serotonin receptors. This unique action helps manage hallucinations without impairing movement. It’s a valuable option for patients whose daily life is disrupted by these challenging non-motor symptoms.

Signs + Treatment = Smarter Care

Recognizing early Parkinson’s symptoms and choosing the right treatment like Nuplazid can improve long-term outcomes. While it’s not a cure, combining symptom-specific medication with lifestyle changes and therapies creates a holistic care plan. Talk to your neurologist about personalized options.